Article
Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity.
PLoS neglected tropical diseases - 1 Jul 2020
Han Jin-Hee, Cho Jee-Sun, Ong Jessica J Y, Park Ji-Hoon, Nyunt Myat Htut, Sutanto Edwin, Trimarsanto Hidayat, Petros Beyene, Aseffa Abraham, Getachew Sisay, Sriprawat Kanlaya, Anstey Nicholas M, Grigg Matthew J, Barber Bridget E, William Timothy, Qi Gao, Liu Yaobao, Pearson Richard D, Auburn Sarah, Price Ric N, Nosten Francois, Rénia Laurent, Russell Bruce, Han Eun-Taek
Abstract excerpt
Plasmodium vivax is the most widespread and difficult to treat cause of human malaria. The development of vaccines against the blood stages of P. vivax remains a key objective for the control and elimination of vivax malaria. Erythrocyte binding-like (EBL) protein family members such as Duffy binding protein (PvDBP) are of critical importance to erythrocyte invasion and have been the major target for vivax...
Topics
- Amino Acid Sequence
- Antibodies, Protozoan
- Asia
- Genetic Variation
- Humans
- Immunity, Humoral
- Malaria, Vivax
- Plasmodium vivax
